Abstract â–¡ 66

There is considerable uncertainty regarding the oxygen saturation threshold below which additional inspired oxygen should be given to infants with acute or chronic lung disease. In the absence of data from controlled studies, recommendations can only be based on reference values for healthy and on observational studies into the pathophysiological effects of acute and chronic hypoxia; there will be summarized in this overview. Studies on reference values for pulse oximeter saturation (SpO2) in term and preterm infants show that, during regular breathing, 95% of infants maintain SpO2 at, or above, 93-97%, depending on age. Studies of infants with chronic lung disease (CLD) show that (i) if SpO2 was kept at 393% via comparatively generous prescription of home oxygen, rates of sudden infants death were reduced, (ii) weight gain was significantly better if SpO2 was maintained at 393-95%, (iii) increasing SpO2 from 82 to 93% by providing low-flow oxygen resulted in a 50% reduction in pulmonary artery pressure, (iv) O2 administration to mildly hypoxemic infants (SpO2 89%) caused a 50% decrease in airway resistance, and (v) low-flow oxygen reduced the frequency of intermittent hypoxemic episodes even in infants who had values of 390% at rest. Based on these data, it is suggested that oxygen therapy should be considered in infants whose baseline SpO2 is <93%, and that SpO2 should be maintained at 395% during therapy.